context stringlengths 21 33.9k | category stringclasses 2
values | entity stringlengths 1 12 | entity_type stringclasses 5
values | query stringlengths 97 3.31k | answer stringlengths 12 169 |
|---|---|---|---|---|---|
In 2022, we entered into an agreement with Celsius to distribute Celsius energy drinks in the United States (see Note 4 for further information) and invested $ 550 million in Series A convertible preferred shares issued by Celsius, which included certain conversion and redemption features. The preferred shares automatically convert into Celsius common shares after six years if certain market-based conditions are met, or can be redeemed after seven years. Shares underlying the transaction were priced at $ 75 per share, and the preferred shares are entitled to a 5 % annual dividend, payable either in cash or in-kind. Given our redemption right, we classified our investment in the convertible preferred stock as an available-for-sale debt security. As of December 31, 2022, the fair value of this investment was classified as Level 2, based primarily on the transaction price. There were no unrealized gains and losses on our investment in the year ended December 31, 2022. In the year ended December 30, 2023, we transferred $ 558 million from Level 2 to Level 3 as unobservable inputs to the fair value became more significant and subsequently recorded an unrealized gain of $ 612 million in other comprehensive income and a decrease in the investment of $ 14 million due to cash dividends received. There were no impairment charges related to our investment in the years ended December 30, 2023 and December 31, 2022. | text | 5 | percentItemType | text: <entity> 5 </entity> <entity type> percentItemType </entity type> <context> In 2022, we entered into an agreement with Celsius to distribute Celsius energy drinks in the United States (see Note 4 for further information) and invested $ 550 million in Series A convertible preferred shares issued by Celsius, which included certain conversion and redemption features. The preferred shares automatically convert into Celsius common shares after six years if certain market-based conditions are met, or can be redeemed after seven years. Shares underlying the transaction were priced at $ 75 per share, and the preferred shares are entitled to a 5 % annual dividend, payable either in cash or in-kind. Given our redemption right, we classified our investment in the convertible preferred stock as an available-for-sale debt security. As of December 31, 2022, the fair value of this investment was classified as Level 2, based primarily on the transaction price. There were no unrealized gains and losses on our investment in the year ended December 31, 2022. In the year ended December 30, 2023, we transferred $ 558 million from Level 2 to Level 3 as unobservable inputs to the fair value became more significant and subsequently recorded an unrealized gain of $ 612 million in other comprehensive income and a decrease in the investment of $ 14 million due to cash dividends received. There were no impairment charges related to our investment in the years ended December 30, 2023 and December 31, 2022. </context> | us-gaap:PreferredStockDividendRatePercentage |
In 2022, we entered into an agreement with Celsius to distribute Celsius energy drinks in the United States (see Note 4 for further information) and invested $ 550 million in Series A convertible preferred shares issued by Celsius, which included certain conversion and redemption features. The preferred shares automatically convert into Celsius common shares after six years if certain market-based conditions are met, or can be redeemed after seven years. Shares underlying the transaction were priced at $ 75 per share, and the preferred shares are entitled to a 5 % annual dividend, payable either in cash or in-kind. Given our redemption right, we classified our investment in the convertible preferred stock as an available-for-sale debt security. As of December 31, 2022, the fair value of this investment was classified as Level 2, based primarily on the transaction price. There were no unrealized gains and losses on our investment in the year ended December 31, 2022. In the year ended December 30, 2023, we transferred $ 558 million from Level 2 to Level 3 as unobservable inputs to the fair value became more significant and subsequently recorded an unrealized gain of $ 612 million in other comprehensive income and a decrease in the investment of $ 14 million due to cash dividends received. There were no impairment charges related to our investment in the years ended December 30, 2023 and December 31, 2022. | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> In 2022, we entered into an agreement with Celsius to distribute Celsius energy drinks in the United States (see Note 4 for further information) and invested $ 550 million in Series A convertible preferred shares issued by Celsius, which included certain conversion and redemption features. The preferred shares automatically convert into Celsius common shares after six years if certain market-based conditions are met, or can be redeemed after seven years. Shares underlying the transaction were priced at $ 75 per share, and the preferred shares are entitled to a 5 % annual dividend, payable either in cash or in-kind. Given our redemption right, we classified our investment in the convertible preferred stock as an available-for-sale debt security. As of December 31, 2022, the fair value of this investment was classified as Level 2, based primarily on the transaction price. There were no unrealized gains and losses on our investment in the year ended December 31, 2022. In the year ended December 30, 2023, we transferred $ 558 million from Level 2 to Level 3 as unobservable inputs to the fair value became more significant and subsequently recorded an unrealized gain of $ 612 million in other comprehensive income and a decrease in the investment of $ 14 million due to cash dividends received. There were no impairment charges related to our investment in the years ended December 30, 2023 and December 31, 2022. </context> | us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss |
In 2022, we entered into an agreement with Celsius to distribute Celsius energy drinks in the United States (see Note 4 for further information) and invested $ 550 million in Series A convertible preferred shares issued by Celsius, which included certain conversion and redemption features. The preferred shares automatically convert into Celsius common shares after six years if certain market-based conditions are met, or can be redeemed after seven years. Shares underlying the transaction were priced at $ 75 per share, and the preferred shares are entitled to a 5 % annual dividend, payable either in cash or in-kind. Given our redemption right, we classified our investment in the convertible preferred stock as an available-for-sale debt security. As of December 31, 2022, the fair value of this investment was classified as Level 2, based primarily on the transaction price. There were no unrealized gains and losses on our investment in the year ended December 31, 2022. In the year ended December 30, 2023, we transferred $ 558 million from Level 2 to Level 3 as unobservable inputs to the fair value became more significant and subsequently recorded an unrealized gain of $ 612 million in other comprehensive income and a decrease in the investment of $ 14 million due to cash dividends received. There were no impairment charges related to our investment in the years ended December 30, 2023 and December 31, 2022. | text | 558 | monetaryItemType | text: <entity> 558 </entity> <entity type> monetaryItemType </entity type> <context> In 2022, we entered into an agreement with Celsius to distribute Celsius energy drinks in the United States (see Note 4 for further information) and invested $ 550 million in Series A convertible preferred shares issued by Celsius, which included certain conversion and redemption features. The preferred shares automatically convert into Celsius common shares after six years if certain market-based conditions are met, or can be redeemed after seven years. Shares underlying the transaction were priced at $ 75 per share, and the preferred shares are entitled to a 5 % annual dividend, payable either in cash or in-kind. Given our redemption right, we classified our investment in the convertible preferred stock as an available-for-sale debt security. As of December 31, 2022, the fair value of this investment was classified as Level 2, based primarily on the transaction price. There were no unrealized gains and losses on our investment in the year ended December 31, 2022. In the year ended December 30, 2023, we transferred $ 558 million from Level 2 to Level 3 as unobservable inputs to the fair value became more significant and subsequently recorded an unrealized gain of $ 612 million in other comprehensive income and a decrease in the investment of $ 14 million due to cash dividends received. There were no impairment charges related to our investment in the years ended December 30, 2023 and December 31, 2022. </context> | us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 |
In 2022, we entered into an agreement with Celsius to distribute Celsius energy drinks in the United States (see Note 4 for further information) and invested $ 550 million in Series A convertible preferred shares issued by Celsius, which included certain conversion and redemption features. The preferred shares automatically convert into Celsius common shares after six years if certain market-based conditions are met, or can be redeemed after seven years. Shares underlying the transaction were priced at $ 75 per share, and the preferred shares are entitled to a 5 % annual dividend, payable either in cash or in-kind. Given our redemption right, we classified our investment in the convertible preferred stock as an available-for-sale debt security. As of December 31, 2022, the fair value of this investment was classified as Level 2, based primarily on the transaction price. There were no unrealized gains and losses on our investment in the year ended December 31, 2022. In the year ended December 30, 2023, we transferred $ 558 million from Level 2 to Level 3 as unobservable inputs to the fair value became more significant and subsequently recorded an unrealized gain of $ 612 million in other comprehensive income and a decrease in the investment of $ 14 million due to cash dividends received. There were no impairment charges related to our investment in the years ended December 30, 2023 and December 31, 2022. | text | 612 | monetaryItemType | text: <entity> 612 </entity> <entity type> monetaryItemType </entity type> <context> In 2022, we entered into an agreement with Celsius to distribute Celsius energy drinks in the United States (see Note 4 for further information) and invested $ 550 million in Series A convertible preferred shares issued by Celsius, which included certain conversion and redemption features. The preferred shares automatically convert into Celsius common shares after six years if certain market-based conditions are met, or can be redeemed after seven years. Shares underlying the transaction were priced at $ 75 per share, and the preferred shares are entitled to a 5 % annual dividend, payable either in cash or in-kind. Given our redemption right, we classified our investment in the convertible preferred stock as an available-for-sale debt security. As of December 31, 2022, the fair value of this investment was classified as Level 2, based primarily on the transaction price. There were no unrealized gains and losses on our investment in the year ended December 31, 2022. In the year ended December 30, 2023, we transferred $ 558 million from Level 2 to Level 3 as unobservable inputs to the fair value became more significant and subsequently recorded an unrealized gain of $ 612 million in other comprehensive income and a decrease in the investment of $ 14 million due to cash dividends received. There were no impairment charges related to our investment in the years ended December 30, 2023 and December 31, 2022. </context> | us-gaap:FairValueRecurringBasisUnobservableInputReconciliationAssetLiabilityGainLossOci |
In 2022, we entered into an agreement with Celsius to distribute Celsius energy drinks in the United States (see Note 4 for further information) and invested $ 550 million in Series A convertible preferred shares issued by Celsius, which included certain conversion and redemption features. The preferred shares automatically convert into Celsius common shares after six years if certain market-based conditions are met, or can be redeemed after seven years. Shares underlying the transaction were priced at $ 75 per share, and the preferred shares are entitled to a 5 % annual dividend, payable either in cash or in-kind. Given our redemption right, we classified our investment in the convertible preferred stock as an available-for-sale debt security. As of December 31, 2022, the fair value of this investment was classified as Level 2, based primarily on the transaction price. There were no unrealized gains and losses on our investment in the year ended December 31, 2022. In the year ended December 30, 2023, we transferred $ 558 million from Level 2 to Level 3 as unobservable inputs to the fair value became more significant and subsequently recorded an unrealized gain of $ 612 million in other comprehensive income and a decrease in the investment of $ 14 million due to cash dividends received. There were no impairment charges related to our investment in the years ended December 30, 2023 and December 31, 2022. | text | 14 | monetaryItemType | text: <entity> 14 </entity> <entity type> monetaryItemType </entity type> <context> In 2022, we entered into an agreement with Celsius to distribute Celsius energy drinks in the United States (see Note 4 for further information) and invested $ 550 million in Series A convertible preferred shares issued by Celsius, which included certain conversion and redemption features. The preferred shares automatically convert into Celsius common shares after six years if certain market-based conditions are met, or can be redeemed after seven years. Shares underlying the transaction were priced at $ 75 per share, and the preferred shares are entitled to a 5 % annual dividend, payable either in cash or in-kind. Given our redemption right, we classified our investment in the convertible preferred stock as an available-for-sale debt security. As of December 31, 2022, the fair value of this investment was classified as Level 2, based primarily on the transaction price. There were no unrealized gains and losses on our investment in the year ended December 31, 2022. In the year ended December 30, 2023, we transferred $ 558 million from Level 2 to Level 3 as unobservable inputs to the fair value became more significant and subsequently recorded an unrealized gain of $ 612 million in other comprehensive income and a decrease in the investment of $ 14 million due to cash dividends received. There were no impairment charges related to our investment in the years ended December 30, 2023 and December 31, 2022. </context> | us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease |
In 2023, we recorded our proportionate share of TBG’s earnings, which includes an impairment of TBG’s indefinite-lived intangible assets, and recorded an other-than-temporary impairment of our investment, both of which resulted in pre-tax impairment charges of $ 321 million ($ 243 million after-tax or $ 0.18 per share), recorded in selling, general and administrative expenses in our PBNA division. We estimated the fair value of our ownership in TBG using discounted cash flows and an option pricing model related to our liquidation preference in TBG, which we categorized as Level 3 (significant unobservable inputs) in the fair value hierarchy. | text | 321 | monetaryItemType | text: <entity> 321 </entity> <entity type> monetaryItemType </entity type> <context> In 2023, we recorded our proportionate share of TBG’s earnings, which includes an impairment of TBG’s indefinite-lived intangible assets, and recorded an other-than-temporary impairment of our investment, both of which resulted in pre-tax impairment charges of $ 321 million ($ 243 million after-tax or $ 0.18 per share), recorded in selling, general and administrative expenses in our PBNA division. We estimated the fair value of our ownership in TBG using discounted cash flows and an option pricing model related to our liquidation preference in TBG, which we categorized as Level 3 (significant unobservable inputs) in the fair value hierarchy. </context> | us-gaap:AssetImpairmentCharges |
In 2023, we recorded our proportionate share of TBG’s earnings, which includes an impairment of TBG’s indefinite-lived intangible assets, and recorded an other-than-temporary impairment of our investment, both of which resulted in pre-tax impairment charges of $ 321 million ($ 243 million after-tax or $ 0.18 per share), recorded in selling, general and administrative expenses in our PBNA division. We estimated the fair value of our ownership in TBG using discounted cash flows and an option pricing model related to our liquidation preference in TBG, which we categorized as Level 3 (significant unobservable inputs) in the fair value hierarchy. | text | 0.18 | perShareItemType | text: <entity> 0.18 </entity> <entity type> perShareItemType </entity type> <context> In 2023, we recorded our proportionate share of TBG’s earnings, which includes an impairment of TBG’s indefinite-lived intangible assets, and recorded an other-than-temporary impairment of our investment, both of which resulted in pre-tax impairment charges of $ 321 million ($ 243 million after-tax or $ 0.18 per share), recorded in selling, general and administrative expenses in our PBNA division. We estimated the fair value of our ownership in TBG using discounted cash flows and an option pricing model related to our liquidation preference in TBG, which we categorized as Level 3 (significant unobservable inputs) in the fair value hierarchy. </context> | us-gaap:ImpairmentEffectOnEarningsPerShareAfterTax |
Includes Level 2 assets of $ 178 million and Level 3 assets of $ 1,156 million as of December 30, 2023, and Level 2 assets of $ 660 million as of December 31, 2022. As of December 30, 2023, $ 1,334 million was classified as other assets. As of December 31, 2022, $ 3 million, $ 104 million and $ 553 million were classified as cash equivalents, short-term investments and other assets, respectively. The fair values of these Level 2 investments approximate the transaction price and any accrued dividends, as well as the amortized cost. The fair value of our Level 3 investment in Celsius is estimated using probability-weighted discounted future cash flows based on a Monte Carlo simulation using significant unobservable inputs such as an 80 % probability that a certain market-based condition will be met and an average estimated discount rate of 8.1 % based on Celsius’ estimated synthetic credit rating. An increase in the probability that certain market-based conditions will be met or a decrease in the discount rate would result in a higher fair value measurement, while a decrease in the probability that certain market-based conditions will be met or an increase in the discount rate would result in a lower fair value measurement. | text | 178 | monetaryItemType | text: <entity> 178 </entity> <entity type> monetaryItemType </entity type> <context> Includes Level 2 assets of $ 178 million and Level 3 assets of $ 1,156 million as of December 30, 2023, and Level 2 assets of $ 660 million as of December 31, 2022. As of December 30, 2023, $ 1,334 million was classified as other assets. As of December 31, 2022, $ 3 million, $ 104 million and $ 553 million were classified as cash equivalents, short-term investments and other assets, respectively. The fair values of these Level 2 investments approximate the transaction price and any accrued dividends, as well as the amortized cost. The fair value of our Level 3 investment in Celsius is estimated using probability-weighted discounted future cash flows based on a Monte Carlo simulation using significant unobservable inputs such as an 80 % probability that a certain market-based condition will be met and an average estimated discount rate of 8.1 % based on Celsius’ estimated synthetic credit rating. An increase in the probability that certain market-based conditions will be met or a decrease in the discount rate would result in a higher fair value measurement, while a decrease in the probability that certain market-based conditions will be met or an increase in the discount rate would result in a lower fair value measurement. </context> | us-gaap:AvailableForSaleSecuritiesDebtSecurities |
Includes Level 2 assets of $ 178 million and Level 3 assets of $ 1,156 million as of December 30, 2023, and Level 2 assets of $ 660 million as of December 31, 2022. As of December 30, 2023, $ 1,334 million was classified as other assets. As of December 31, 2022, $ 3 million, $ 104 million and $ 553 million were classified as cash equivalents, short-term investments and other assets, respectively. The fair values of these Level 2 investments approximate the transaction price and any accrued dividends, as well as the amortized cost. The fair value of our Level 3 investment in Celsius is estimated using probability-weighted discounted future cash flows based on a Monte Carlo simulation using significant unobservable inputs such as an 80 % probability that a certain market-based condition will be met and an average estimated discount rate of 8.1 % based on Celsius’ estimated synthetic credit rating. An increase in the probability that certain market-based conditions will be met or a decrease in the discount rate would result in a higher fair value measurement, while a decrease in the probability that certain market-based conditions will be met or an increase in the discount rate would result in a lower fair value measurement. | text | 1156 | monetaryItemType | text: <entity> 1156 </entity> <entity type> monetaryItemType </entity type> <context> Includes Level 2 assets of $ 178 million and Level 3 assets of $ 1,156 million as of December 30, 2023, and Level 2 assets of $ 660 million as of December 31, 2022. As of December 30, 2023, $ 1,334 million was classified as other assets. As of December 31, 2022, $ 3 million, $ 104 million and $ 553 million were classified as cash equivalents, short-term investments and other assets, respectively. The fair values of these Level 2 investments approximate the transaction price and any accrued dividends, as well as the amortized cost. The fair value of our Level 3 investment in Celsius is estimated using probability-weighted discounted future cash flows based on a Monte Carlo simulation using significant unobservable inputs such as an 80 % probability that a certain market-based condition will be met and an average estimated discount rate of 8.1 % based on Celsius’ estimated synthetic credit rating. An increase in the probability that certain market-based conditions will be met or a decrease in the discount rate would result in a higher fair value measurement, while a decrease in the probability that certain market-based conditions will be met or an increase in the discount rate would result in a lower fair value measurement. </context> | us-gaap:AvailableForSaleSecuritiesDebtSecurities |
Includes Level 2 assets of $ 178 million and Level 3 assets of $ 1,156 million as of December 30, 2023, and Level 2 assets of $ 660 million as of December 31, 2022. As of December 30, 2023, $ 1,334 million was classified as other assets. As of December 31, 2022, $ 3 million, $ 104 million and $ 553 million were classified as cash equivalents, short-term investments and other assets, respectively. The fair values of these Level 2 investments approximate the transaction price and any accrued dividends, as well as the amortized cost. The fair value of our Level 3 investment in Celsius is estimated using probability-weighted discounted future cash flows based on a Monte Carlo simulation using significant unobservable inputs such as an 80 % probability that a certain market-based condition will be met and an average estimated discount rate of 8.1 % based on Celsius’ estimated synthetic credit rating. An increase in the probability that certain market-based conditions will be met or a decrease in the discount rate would result in a higher fair value measurement, while a decrease in the probability that certain market-based conditions will be met or an increase in the discount rate would result in a lower fair value measurement. | text | 660 | monetaryItemType | text: <entity> 660 </entity> <entity type> monetaryItemType </entity type> <context> Includes Level 2 assets of $ 178 million and Level 3 assets of $ 1,156 million as of December 30, 2023, and Level 2 assets of $ 660 million as of December 31, 2022. As of December 30, 2023, $ 1,334 million was classified as other assets. As of December 31, 2022, $ 3 million, $ 104 million and $ 553 million were classified as cash equivalents, short-term investments and other assets, respectively. The fair values of these Level 2 investments approximate the transaction price and any accrued dividends, as well as the amortized cost. The fair value of our Level 3 investment in Celsius is estimated using probability-weighted discounted future cash flows based on a Monte Carlo simulation using significant unobservable inputs such as an 80 % probability that a certain market-based condition will be met and an average estimated discount rate of 8.1 % based on Celsius’ estimated synthetic credit rating. An increase in the probability that certain market-based conditions will be met or a decrease in the discount rate would result in a higher fair value measurement, while a decrease in the probability that certain market-based conditions will be met or an increase in the discount rate would result in a lower fair value measurement. </context> | us-gaap:AvailableForSaleSecuritiesDebtSecurities |
Includes Level 2 assets of $ 178 million and Level 3 assets of $ 1,156 million as of December 30, 2023, and Level 2 assets of $ 660 million as of December 31, 2022. As of December 30, 2023, $ 1,334 million was classified as other assets. As of December 31, 2022, $ 3 million, $ 104 million and $ 553 million were classified as cash equivalents, short-term investments and other assets, respectively. The fair values of these Level 2 investments approximate the transaction price and any accrued dividends, as well as the amortized cost. The fair value of our Level 3 investment in Celsius is estimated using probability-weighted discounted future cash flows based on a Monte Carlo simulation using significant unobservable inputs such as an 80 % probability that a certain market-based condition will be met and an average estimated discount rate of 8.1 % based on Celsius’ estimated synthetic credit rating. An increase in the probability that certain market-based conditions will be met or a decrease in the discount rate would result in a higher fair value measurement, while a decrease in the probability that certain market-based conditions will be met or an increase in the discount rate would result in a lower fair value measurement. | text | 3 | monetaryItemType | text: <entity> 3 </entity> <entity type> monetaryItemType </entity type> <context> Includes Level 2 assets of $ 178 million and Level 3 assets of $ 1,156 million as of December 30, 2023, and Level 2 assets of $ 660 million as of December 31, 2022. As of December 30, 2023, $ 1,334 million was classified as other assets. As of December 31, 2022, $ 3 million, $ 104 million and $ 553 million were classified as cash equivalents, short-term investments and other assets, respectively. The fair values of these Level 2 investments approximate the transaction price and any accrued dividends, as well as the amortized cost. The fair value of our Level 3 investment in Celsius is estimated using probability-weighted discounted future cash flows based on a Monte Carlo simulation using significant unobservable inputs such as an 80 % probability that a certain market-based condition will be met and an average estimated discount rate of 8.1 % based on Celsius’ estimated synthetic credit rating. An increase in the probability that certain market-based conditions will be met or a decrease in the discount rate would result in a higher fair value measurement, while a decrease in the probability that certain market-based conditions will be met or an increase in the discount rate would result in a lower fair value measurement. </context> | us-gaap:AvailableForSaleSecuritiesDebtSecurities |
Includes Level 2 assets of $ 178 million and Level 3 assets of $ 1,156 million as of December 30, 2023, and Level 2 assets of $ 660 million as of December 31, 2022. As of December 30, 2023, $ 1,334 million was classified as other assets. As of December 31, 2022, $ 3 million, $ 104 million and $ 553 million were classified as cash equivalents, short-term investments and other assets, respectively. The fair values of these Level 2 investments approximate the transaction price and any accrued dividends, as well as the amortized cost. The fair value of our Level 3 investment in Celsius is estimated using probability-weighted discounted future cash flows based on a Monte Carlo simulation using significant unobservable inputs such as an 80 % probability that a certain market-based condition will be met and an average estimated discount rate of 8.1 % based on Celsius’ estimated synthetic credit rating. An increase in the probability that certain market-based conditions will be met or a decrease in the discount rate would result in a higher fair value measurement, while a decrease in the probability that certain market-based conditions will be met or an increase in the discount rate would result in a lower fair value measurement. | text | 104 | monetaryItemType | text: <entity> 104 </entity> <entity type> monetaryItemType </entity type> <context> Includes Level 2 assets of $ 178 million and Level 3 assets of $ 1,156 million as of December 30, 2023, and Level 2 assets of $ 660 million as of December 31, 2022. As of December 30, 2023, $ 1,334 million was classified as other assets. As of December 31, 2022, $ 3 million, $ 104 million and $ 553 million were classified as cash equivalents, short-term investments and other assets, respectively. The fair values of these Level 2 investments approximate the transaction price and any accrued dividends, as well as the amortized cost. The fair value of our Level 3 investment in Celsius is estimated using probability-weighted discounted future cash flows based on a Monte Carlo simulation using significant unobservable inputs such as an 80 % probability that a certain market-based condition will be met and an average estimated discount rate of 8.1 % based on Celsius’ estimated synthetic credit rating. An increase in the probability that certain market-based conditions will be met or a decrease in the discount rate would result in a higher fair value measurement, while a decrease in the probability that certain market-based conditions will be met or an increase in the discount rate would result in a lower fair value measurement. </context> | us-gaap:AvailableForSaleSecuritiesDebtSecurities |
Includes Level 2 assets of $ 178 million and Level 3 assets of $ 1,156 million as of December 30, 2023, and Level 2 assets of $ 660 million as of December 31, 2022. As of December 30, 2023, $ 1,334 million was classified as other assets. As of December 31, 2022, $ 3 million, $ 104 million and $ 553 million were classified as cash equivalents, short-term investments and other assets, respectively. The fair values of these Level 2 investments approximate the transaction price and any accrued dividends, as well as the amortized cost. The fair value of our Level 3 investment in Celsius is estimated using probability-weighted discounted future cash flows based on a Monte Carlo simulation using significant unobservable inputs such as an 80 % probability that a certain market-based condition will be met and an average estimated discount rate of 8.1 % based on Celsius’ estimated synthetic credit rating. An increase in the probability that certain market-based conditions will be met or a decrease in the discount rate would result in a higher fair value measurement, while a decrease in the probability that certain market-based conditions will be met or an increase in the discount rate would result in a lower fair value measurement. | text | 553 | monetaryItemType | text: <entity> 553 </entity> <entity type> monetaryItemType </entity type> <context> Includes Level 2 assets of $ 178 million and Level 3 assets of $ 1,156 million as of December 30, 2023, and Level 2 assets of $ 660 million as of December 31, 2022. As of December 30, 2023, $ 1,334 million was classified as other assets. As of December 31, 2022, $ 3 million, $ 104 million and $ 553 million were classified as cash equivalents, short-term investments and other assets, respectively. The fair values of these Level 2 investments approximate the transaction price and any accrued dividends, as well as the amortized cost. The fair value of our Level 3 investment in Celsius is estimated using probability-weighted discounted future cash flows based on a Monte Carlo simulation using significant unobservable inputs such as an 80 % probability that a certain market-based condition will be met and an average estimated discount rate of 8.1 % based on Celsius’ estimated synthetic credit rating. An increase in the probability that certain market-based conditions will be met or a decrease in the discount rate would result in a higher fair value measurement, while a decrease in the probability that certain market-based conditions will be met or an increase in the discount rate would result in a lower fair value measurement. </context> | us-gaap:AvailableForSaleSecuritiesDebtSecurities |
The carrying amounts of our cash and cash equivalents and short-term investments recorded at amortized cost approximate fair value (classified as Level 2 in the fair value hierarchy) due to their short-term maturity. The fair value of our debt obligations as of December 30, 2023 and December 31, 2022 was $ 41 billion and $ 35 billion, respectively, based upon prices of identical or similar instruments in the marketplace, which are considered Level 2 inputs. | text | 41 | monetaryItemType | text: <entity> 41 </entity> <entity type> monetaryItemType </entity type> <context> The carrying amounts of our cash and cash equivalents and short-term investments recorded at amortized cost approximate fair value (classified as Level 2 in the fair value hierarchy) due to their short-term maturity. The fair value of our debt obligations as of December 30, 2023 and December 31, 2022 was $ 41 billion and $ 35 billion, respectively, based upon prices of identical or similar instruments in the marketplace, which are considered Level 2 inputs. </context> | us-gaap:DebtInstrumentFairValue |
The carrying amounts of our cash and cash equivalents and short-term investments recorded at amortized cost approximate fair value (classified as Level 2 in the fair value hierarchy) due to their short-term maturity. The fair value of our debt obligations as of December 30, 2023 and December 31, 2022 was $ 41 billion and $ 35 billion, respectively, based upon prices of identical or similar instruments in the marketplace, which are considered Level 2 inputs. | text | 35 | monetaryItemType | text: <entity> 35 </entity> <entity type> monetaryItemType </entity type> <context> The carrying amounts of our cash and cash equivalents and short-term investments recorded at amortized cost approximate fair value (classified as Level 2 in the fair value hierarchy) due to their short-term maturity. The fair value of our debt obligations as of December 30, 2023 and December 31, 2022 was $ 41 billion and $ 35 billion, respectively, based upon prices of identical or similar instruments in the marketplace, which are considered Level 2 inputs. </context> | us-gaap:DebtInstrumentFairValue |
Based on current market conditions, we expect to reclassify net losses of $ 112 million related to our cash flow hedges from accumulated other comprehensive loss within common shareholders’ equity into net income during the next 12 months. | text | 112 | monetaryItemType | text: <entity> 112 </entity> <entity type> monetaryItemType </entity type> <context> Based on current market conditions, we expect to reclassify net losses of $ 112 million related to our cash flow hedges from accumulated other comprehensive loss within common shareholders’ equity into net income during the next 12 months. </context> | us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths |
Includes right-of-use asset amortization of $ 570 million, $ 517 million, and $ 505 million in 2023, 2022, and 2021, respectively. | text | 570 | monetaryItemType | text: <entity> 570 </entity> <entity type> monetaryItemType </entity type> <context> Includes right-of-use asset amortization of $ 570 million, $ 517 million, and $ 505 million in 2023, 2022, and 2021, respectively. </context> | us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense |
Includes right-of-use asset amortization of $ 570 million, $ 517 million, and $ 505 million in 2023, 2022, and 2021, respectively. | text | 517 | monetaryItemType | text: <entity> 517 </entity> <entity type> monetaryItemType </entity type> <context> Includes right-of-use asset amortization of $ 570 million, $ 517 million, and $ 505 million in 2023, 2022, and 2021, respectively. </context> | us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense |
Includes right-of-use asset amortization of $ 570 million, $ 517 million, and $ 505 million in 2023, 2022, and 2021, respectively. | text | 505 | monetaryItemType | text: <entity> 505 </entity> <entity type> monetaryItemType </entity type> <context> Includes right-of-use asset amortization of $ 570 million, $ 517 million, and $ 505 million in 2023, 2022, and 2021, respectively. </context> | us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense |
In 2023, 2022 and 2021, we recognized gains of $ 52 million, $ 175 million and $ 42 million, respectively, on sale-leaseback transactions with terms under five years. | text | 52 | monetaryItemType | text: <entity> 52 </entity> <entity type> monetaryItemType </entity type> <context> In 2023, 2022 and 2021, we recognized gains of $ 52 million, $ 175 million and $ 42 million, respectively, on sale-leaseback transactions with terms under five years. </context> | us-gaap:SaleAndLeasebackTransactionGainLossNet |
In 2023, 2022 and 2021, we recognized gains of $ 52 million, $ 175 million and $ 42 million, respectively, on sale-leaseback transactions with terms under five years. | text | 175 | monetaryItemType | text: <entity> 175 </entity> <entity type> monetaryItemType </entity type> <context> In 2023, 2022 and 2021, we recognized gains of $ 52 million, $ 175 million and $ 42 million, respectively, on sale-leaseback transactions with terms under five years. </context> | us-gaap:SaleAndLeasebackTransactionGainLossNet |
In 2023, 2022 and 2021, we recognized gains of $ 52 million, $ 175 million and $ 42 million, respectively, on sale-leaseback transactions with terms under five years. | text | 42 | monetaryItemType | text: <entity> 42 </entity> <entity type> monetaryItemType </entity type> <context> In 2023, 2022 and 2021, we recognized gains of $ 52 million, $ 175 million and $ 42 million, respectively, on sale-leaseback transactions with terms under five years. </context> | us-gaap:SaleAndLeasebackTransactionGainLossNet |
In the first quarter of 2022, we sold our Tropicana, Naked and other select juice brands to PAI Partners for approximately $ 3.5 billion in cash, subject to purchase price adjustments, and a 39 % noncontrolling interest in TBG, operating across North America and Europe. The North America portion of the transaction was completed on January 24, 2022 and the Europe portion of the transaction was completed on February 1, 2022. In the United States, PepsiCo acts as the exclusive distributor for TBG’s portfolio of brands for small-format and foodservice customers with chilled DSD. We have significant influence over our investment in TBG and account for our investment under the equity method, recognizing our proportionate share of TBG’s earnings on our income statement (recorded in selling, general and administrative expenses). | text | 3.5 | monetaryItemType | text: <entity> 3.5 </entity> <entity type> monetaryItemType </entity type> <context> In the first quarter of 2022, we sold our Tropicana, Naked and other select juice brands to PAI Partners for approximately $ 3.5 billion in cash, subject to purchase price adjustments, and a 39 % noncontrolling interest in TBG, operating across North America and Europe. The North America portion of the transaction was completed on January 24, 2022 and the Europe portion of the transaction was completed on February 1, 2022. In the United States, PepsiCo acts as the exclusive distributor for TBG’s portfolio of brands for small-format and foodservice customers with chilled DSD. We have significant influence over our investment in TBG and account for our investment under the equity method, recognizing our proportionate share of TBG’s earnings on our income statement (recorded in selling, general and administrative expenses). </context> | us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration |
In the first quarter of 2022, we sold our Tropicana, Naked and other select juice brands to PAI Partners for approximately $ 3.5 billion in cash, subject to purchase price adjustments, and a 39 % noncontrolling interest in TBG, operating across North America and Europe. The North America portion of the transaction was completed on January 24, 2022 and the Europe portion of the transaction was completed on February 1, 2022. In the United States, PepsiCo acts as the exclusive distributor for TBG’s portfolio of brands for small-format and foodservice customers with chilled DSD. We have significant influence over our investment in TBG and account for our investment under the equity method, recognizing our proportionate share of TBG’s earnings on our income statement (recorded in selling, general and administrative expenses). | text | 39 | percentItemType | text: <entity> 39 </entity> <entity type> percentItemType </entity type> <context> In the first quarter of 2022, we sold our Tropicana, Naked and other select juice brands to PAI Partners for approximately $ 3.5 billion in cash, subject to purchase price adjustments, and a 39 % noncontrolling interest in TBG, operating across North America and Europe. The North America portion of the transaction was completed on January 24, 2022 and the Europe portion of the transaction was completed on February 1, 2022. In the United States, PepsiCo acts as the exclusive distributor for TBG’s portfolio of brands for small-format and foodservice customers with chilled DSD. We have significant influence over our investment in TBG and account for our investment under the equity method, recognizing our proportionate share of TBG’s earnings on our income statement (recorded in selling, general and administrative expenses). </context> | us-gaap:EquityMethodInvestmentOwnershipPercentage |
As a result of this transaction, in the year ended December 31, 2022, we recorded a gain in our PBNA and Europe divisions (see detailed income statement activity below), including $ 520 million related to the remeasurement of our 39 % ownership in TBG at fair value using a combination of the transaction price, discounted cash flo | text | 520 | monetaryItemType | text: <entity> 520 </entity> <entity type> monetaryItemType </entity type> <context> As a result of this transaction, in the year ended December 31, 2022, we recorded a gain in our PBNA and Europe divisions (see detailed income statement activity below), including $ 520 million related to the remeasurement of our 39 % ownership in TBG at fair value using a combination of the transaction price, discounted cash flo </context> | us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity |
As a result of this transaction, in the year ended December 31, 2022, we recorded a gain in our PBNA and Europe divisions (see detailed income statement activity below), including $ 520 million related to the remeasurement of our 39 % ownership in TBG at fair value using a combination of the transaction price, discounted cash flo | text | 39 | percentItemType | text: <entity> 39 </entity> <entity type> percentItemType </entity type> <context> As a result of this transaction, in the year ended December 31, 2022, we recorded a gain in our PBNA and Europe divisions (see detailed income statement activity below), including $ 520 million related to the remeasurement of our 39 % ownership in TBG at fair value using a combination of the transaction price, discounted cash flo </context> | us-gaap:EquityMethodInvestmentOwnershipPercentage |
Includes $ 16 million curtailment gain, partially offset by $ 6 million special termination benefits. | text | 16 | monetaryItemType | text: <entity> 16 </entity> <entity type> monetaryItemType </entity type> <context> Includes $ 16 million curtailment gain, partially offset by $ 6 million special termination benefits. </context> | us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments |
Includes $ 16 million curtailment gain, partially offset by $ 6 million special termination benefits. | text | 6 | monetaryItemType | text: <entity> 6 </entity> <entity type> monetaryItemType </entity type> <context> Includes $ 16 million curtailment gain, partially offset by $ 6 million special termination benefits. </context> | us-gaap:BusinessCombinationIntegrationRelatedCosts |
The Juice Transaction did not meet the criteria to be classified as discontinued operations. As of December 30, 2023 and December 31, 2022, there were no amounts classified as held for sale. | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> The Juice Transaction did not meet the criteria to be classified as discontinued operations. As of December 30, 2023 and December 31, 2022, there were no amounts classified as held for sale. </context> | us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation |
Marsh & McLennan Companies, Inc., and its consolidated subsidiaries (the "Company"), a global professional services firm, is organized based on the different services that it offers. Under this structure, the Company’s two business segments are Risk and Insurance Services and Consulting. | text | two | integerItemType | text: <entity> two </entity> <entity type> integerItemType </entity type> <context> Marsh & McLennan Companies, Inc., and its consolidated subsidiaries (the "Company"), a global professional services firm, is organized based on the different services that it offers. Under this structure, the Company’s two business segments are Risk and Insurance Services and Consulting. </context> | us-gaap:NumberOfOperatingSegments |
Cash and cash equivalents primarily consist of certificates of deposit and time deposits, with original maturities of three months or less, and money market funds. The estimated fair value of the Company's cash and cash equivalents approximates their carrying value. The Company is required to maintain operating funds primarily related to regulatory requirements outside of the U.S. or as collateral under captive insurance arrangements. At December 31, 2024, the Company maintained $ 455 million compared to $ 486 million at December 31, 2023 related to these regulatory requirements. | text | 455 | monetaryItemType | text: <entity> 455 </entity> <entity type> monetaryItemType </entity type> <context> Cash and cash equivalents primarily consist of certificates of deposit and time deposits, with original maturities of three months or less, and money market funds. The estimated fair value of the Company's cash and cash equivalents approximates their carrying value. The Company is required to maintain operating funds primarily related to regulatory requirements outside of the U.S. or as collateral under captive insurance arrangements. At December 31, 2024, the Company maintained $ 455 million compared to $ 486 million at December 31, 2023 related to these regulatory requirements. </context> | us-gaap:RestrictedCashCurrent |
Cash and cash equivalents primarily consist of certificates of deposit and time deposits, with original maturities of three months or less, and money market funds. The estimated fair value of the Company's cash and cash equivalents approximates their carrying value. The Company is required to maintain operating funds primarily related to regulatory requirements outside of the U.S. or as collateral under captive insurance arrangements. At December 31, 2024, the Company maintained $ 455 million compared to $ 486 million at December 31, 2023 related to these regulatory requirements. | text | 486 | monetaryItemType | text: <entity> 486 </entity> <entity type> monetaryItemType </entity type> <context> Cash and cash equivalents primarily consist of certificates of deposit and time deposits, with original maturities of three months or less, and money market funds. The estimated fair value of the Company's cash and cash equivalents approximates their carrying value. The Company is required to maintain operating funds primarily related to regulatory requirements outside of the U.S. or as collateral under captive insurance arrangements. At December 31, 2024, the Company maintained $ 455 million compared to $ 486 million at December 31, 2023 related to these regulatory requirements. </context> | us-gaap:RestrictedCashCurrent |
In 2024, the Company recorded net investment income of $ 12 million, compared to $ 5 million in 2023, and $ 21 million in 2022. | text | 12 | monetaryItemType | text: <entity> 12 </entity> <entity type> monetaryItemType </entity type> <context> In 2024, the Company recorded net investment income of $ 12 million, compared to $ 5 million in 2023, and $ 21 million in 2022. </context> | us-gaap:GainLossOnInvestments |
In 2024, the Company recorded net investment income of $ 12 million, compared to $ 5 million in 2023, and $ 21 million in 2022. | text | 5 | monetaryItemType | text: <entity> 5 </entity> <entity type> monetaryItemType </entity type> <context> In 2024, the Company recorded net investment income of $ 12 million, compared to $ 5 million in 2023, and $ 21 million in 2022. </context> | us-gaap:GainLossOnInvestments |
In 2024, the Company recorded net investment income of $ 12 million, compared to $ 5 million in 2023, and $ 21 million in 2022. | text | 21 | monetaryItemType | text: <entity> 21 </entity> <entity type> monetaryItemType </entity type> <context> In 2024, the Company recorded net investment income of $ 12 million, compared to $ 5 million in 2023, and $ 21 million in 2022. </context> | us-gaap:GainLossOnInvestments |
Leases are negotiated with third-parties and, in some instances, contain renewal, expansion and termination options. The Company also sub-leases certain office facilities to third-parties when the Company no longer utilizes the space. In addition to the base rental costs, the Company's lease agreements generally provide for rent escalations resulting from increased assessments for real estate taxes and other charges. A portion of the Company's real estate lease portfolio contains base rents subject to annual changes in the Consumer Price Index ("CPI") as well as charges for operating expenses which are reimbursable to the landlord based on actual usage. Changes to the CPI and payments for such reimbursable operating expenses are considered variable and are recognized as variable lease costs in the period in which the obligation for those payments was incurred. Approximately 98 % of the Company's lease obligations are for the use of office space. All of the Company's material leases are operating leases. | text | 98 | percentItemType | text: <entity> 98 </entity> <entity type> percentItemType </entity type> <context> Leases are negotiated with third-parties and, in some instances, contain renewal, expansion and termination options. The Company also sub-leases certain office facilities to third-parties when the Company no longer utilizes the space. In addition to the base rental costs, the Company's lease agreements generally provide for rent escalations resulting from increased assessments for real estate taxes and other charges. A portion of the Company's real estate lease portfolio contains base rents subject to annual changes in the Consumer Price Index ("CPI") as well as charges for operating expenses which are reimbursable to the landlord based on actual usage. Changes to the CPI and payments for such reimbursable operating expenses are considered variable and are recognized as variable lease costs in the period in which the obligation for those payments was incurred. Approximately 98 % of the Company's lease obligations are for the use of office space. All of the Company's material leases are operating leases. </context> | us-gaap:ConcentrationRiskPercentage1 |
The Company capitalizes certain costs to develop, purchase or modify software for the internal use of the Company. These costs are amortized on a straight-line basis over periods ranging from 3 to 10 years. Costs incurred during the preliminary project stage and post implementation stage are expensed as incurred. Costs incurred during the application development stage are capitalized. Costs related to updates and enhancements are only capitalized if they will result in additional functionality. Capitalized computer software costs of $ 474 million and $ 519 million, net of accumulated amortization of $ 2.1 billion and $ 2 billion at December 31, 2024 and 2023, respectively, are included in other assets in the consolidated balance sheets. | text | 474 | monetaryItemType | text: <entity> 474 </entity> <entity type> monetaryItemType </entity type> <context> The Company capitalizes certain costs to develop, purchase or modify software for the internal use of the Company. These costs are amortized on a straight-line basis over periods ranging from 3 to 10 years. Costs incurred during the preliminary project stage and post implementation stage are expensed as incurred. Costs incurred during the application development stage are capitalized. Costs related to updates and enhancements are only capitalized if they will result in additional functionality. Capitalized computer software costs of $ 474 million and $ 519 million, net of accumulated amortization of $ 2.1 billion and $ 2 billion at December 31, 2024 and 2023, respectively, are included in other assets in the consolidated balance sheets. </context> | us-gaap:CapitalizedComputerSoftwareNet |
The Company capitalizes certain costs to develop, purchase or modify software for the internal use of the Company. These costs are amortized on a straight-line basis over periods ranging from 3 to 10 years. Costs incurred during the preliminary project stage and post implementation stage are expensed as incurred. Costs incurred during the application development stage are capitalized. Costs related to updates and enhancements are only capitalized if they will result in additional functionality. Capitalized computer software costs of $ 474 million and $ 519 million, net of accumulated amortization of $ 2.1 billion and $ 2 billion at December 31, 2024 and 2023, respectively, are included in other assets in the consolidated balance sheets. | text | 519 | monetaryItemType | text: <entity> 519 </entity> <entity type> monetaryItemType </entity type> <context> The Company capitalizes certain costs to develop, purchase or modify software for the internal use of the Company. These costs are amortized on a straight-line basis over periods ranging from 3 to 10 years. Costs incurred during the preliminary project stage and post implementation stage are expensed as incurred. Costs incurred during the application development stage are capitalized. Costs related to updates and enhancements are only capitalized if they will result in additional functionality. Capitalized computer software costs of $ 474 million and $ 519 million, net of accumulated amortization of $ 2.1 billion and $ 2 billion at December 31, 2024 and 2023, respectively, are included in other assets in the consolidated balance sheets. </context> | us-gaap:CapitalizedComputerSoftwareNet |
The Company capitalizes certain costs to develop, purchase or modify software for the internal use of the Company. These costs are amortized on a straight-line basis over periods ranging from 3 to 10 years. Costs incurred during the preliminary project stage and post implementation stage are expensed as incurred. Costs incurred during the application development stage are capitalized. Costs related to updates and enhancements are only capitalized if they will result in additional functionality. Capitalized computer software costs of $ 474 million and $ 519 million, net of accumulated amortization of $ 2.1 billion and $ 2 billion at December 31, 2024 and 2023, respectively, are included in other assets in the consolidated balance sheets. | text | 2.1 | monetaryItemType | text: <entity> 2.1 </entity> <entity type> monetaryItemType </entity type> <context> The Company capitalizes certain costs to develop, purchase or modify software for the internal use of the Company. These costs are amortized on a straight-line basis over periods ranging from 3 to 10 years. Costs incurred during the preliminary project stage and post implementation stage are expensed as incurred. Costs incurred during the application development stage are capitalized. Costs related to updates and enhancements are only capitalized if they will result in additional functionality. Capitalized computer software costs of $ 474 million and $ 519 million, net of accumulated amortization of $ 2.1 billion and $ 2 billion at December 31, 2024 and 2023, respectively, are included in other assets in the consolidated balance sheets. </context> | us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization |
The Company capitalizes certain costs to develop, purchase or modify software for the internal use of the Company. These costs are amortized on a straight-line basis over periods ranging from 3 to 10 years. Costs incurred during the preliminary project stage and post implementation stage are expensed as incurred. Costs incurred during the application development stage are capitalized. Costs related to updates and enhancements are only capitalized if they will result in additional functionality. Capitalized computer software costs of $ 474 million and $ 519 million, net of accumulated amortization of $ 2.1 billion and $ 2 billion at December 31, 2024 and 2023, respectively, are included in other assets in the consolidated balance sheets. | text | 2 | monetaryItemType | text: <entity> 2 </entity> <entity type> monetaryItemType </entity type> <context> The Company capitalizes certain costs to develop, purchase or modify software for the internal use of the Company. These costs are amortized on a straight-line basis over periods ranging from 3 to 10 years. Costs incurred during the preliminary project stage and post implementation stage are expensed as incurred. Costs incurred during the application development stage are capitalized. Costs related to updates and enhancements are only capitalized if they will result in additional functionality. Capitalized computer software costs of $ 474 million and $ 519 million, net of accumulated amortization of $ 2.1 billion and $ 2 billion at December 31, 2024 and 2023, respectively, are included in other assets in the consolidated balance sheets. </context> | us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization |
Revenue in 2023 includes a gain from a legal settlement with a competitor of $ 58 million, excluding legal fees. | text | 58 | monetaryItemType | text: <entity> 58 </entity> <entity type> monetaryItemType </entity type> <context> Revenue in 2023 includes a gain from a legal settlement with a competitor of $ 58 million, excluding legal fees. </context> | us-gaap:GainLossRelatedToLitigationSettlement |
includes a net gain of $ 35 million from the sale of the U.K. pension administration and U.S.health and benefits administration businesses, that comprised of a $ 70 million gain in Wealth, offset by a $ 35 million loss in Health. | text | 35 | monetaryItemType | text: <entity> 35 </entity> <entity type> monetaryItemType </entity type> <context> includes a net gain of $ 35 million from the sale of the U.K. pension administration and U.S.health and benefits administration businesses, that comprised of a $ 70 million gain in Wealth, offset by a $ 35 million loss in Health. </context> | us-gaap:GainLossOnSaleOfBusiness |
includes a net gain of $ 35 million from the sale of the U.K. pension administration and U.S.health and benefits administration businesses, that comprised of a $ 70 million gain in Wealth, offset by a $ 35 million loss in Health. | text | 70 | monetaryItemType | text: <entity> 70 </entity> <entity type> monetaryItemType </entity type> <context> includes a net gain of $ 35 million from the sale of the U.K. pension administration and U.S.health and benefits administration businesses, that comprised of a $ 70 million gain in Wealth, offset by a $ 35 million loss in Health. </context> | us-gaap:GainLossOnSaleOfBusiness |
Revenue in 2023 includes the loss on sale of an individual financial advisory business in Canada of $ 17 million. | text | 17 | monetaryItemType | text: <entity> 17 </entity> <entity type> monetaryItemType </entity type> <context> Revenue in 2023 includes the loss on sale of an individual financial advisory business in Canada of $ 17 million. </context> | us-gaap:GainLossOnSaleOfBusiness |
Revenue in 2022 includes a net gain from the sale of the Mercer U.S. affinity business of $ 112 million. | text | 112 | monetaryItemType | text: <entity> 112 </entity> <entity type> monetaryItemType </entity type> <context> Revenue in 2022 includes a net gain from the sale of the Mercer U.S. affinity business of $ 112 million. </context> | us-gaap:GainLossOnSaleOfBusiness |
Revenue in 2024 includes a gain of $ 20 million from the sale of a business in Oliver Wyman Group. | text | 20 | monetaryItemType | text: <entity> 20 </entity> <entity type> monetaryItemType </entity type> <context> Revenue in 2024 includes a gain of $ 20 million from the sale of a business in Oliver Wyman Group. </context> | us-gaap:GainLossOnSaleOfBusiness |
Includes $ 69 million from the acquisition of McGriff in 2024. | text | 69 | monetaryItemType | text: <entity> 69 </entity> <entity type> monetaryItemType </entity type> <context> Includes $ 69 million from the acquisition of McGriff in 2024. </context> | us-gaap:ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress |
$ 73 million, $ 71 million, and $ 83 million, respectively. | text | 73 | monetaryItemType | text: <entity> 73 </entity> <entity type> monetaryItemType </entity type> <context> $ 73 million, $ 71 million, and $ 83 million, respectively. </context> | us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod |
$ 73 million, $ 71 million, and $ 83 million, respectively. | text | 71 | monetaryItemType | text: <entity> 71 </entity> <entity type> monetaryItemType </entity type> <context> $ 73 million, $ 71 million, and $ 83 million, respectively. </context> | us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod |
$ 73 million, $ 71 million, and $ 83 million, respectively. | text | 83 | monetaryItemType | text: <entity> 83 </entity> <entity type> monetaryItemType </entity type> <context> $ 73 million, $ 71 million, and $ 83 million, respectively. </context> | us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod |
$ 3 million, $ 396 million and $ 397 million, | text | 3 | monetaryItemType | text: <entity> 3 </entity> <entity type> monetaryItemType </entity type> <context> $ 3 million, $ 396 million and $ 397 million, </context> | us-gaap:CapitalizedContractCostNet |
$ 3 million, $ 396 million and $ 397 million, | text | 396 | monetaryItemType | text: <entity> 396 </entity> <entity type> monetaryItemType </entity type> <context> $ 3 million, $ 396 million and $ 397 million, </context> | us-gaap:CapitalizedContractCostNet |
$ 3 million, $ 396 million and $ 397 million, | text | 397 | monetaryItemType | text: <entity> 397 </entity> <entity type> monetaryItemType </entity type> <context> $ 3 million, $ 396 million and $ 397 million, </context> | us-gaap:CapitalizedContractCostNet |
respectively. At December 31, 2023, the Company's capitalized assets related to deferred implementation costs, costs to obtain and costs to fulfill were $ 10 million, $ 362 million and $ 370 million, respectively. Costs to obtain and deferred implementation costs are primarily included in other assets and costs to fulfill are primarily included in other current assets in the Company's consolidated balance sheets. The Company recorded compensation and benefits expense of | text | 10 | monetaryItemType | text: <entity> 10 </entity> <entity type> monetaryItemType </entity type> <context> respectively. At December 31, 2023, the Company's capitalized assets related to deferred implementation costs, costs to obtain and costs to fulfill were $ 10 million, $ 362 million and $ 370 million, respectively. Costs to obtain and deferred implementation costs are primarily included in other assets and costs to fulfill are primarily included in other current assets in the Company's consolidated balance sheets. The Company recorded compensation and benefits expense of </context> | us-gaap:CapitalizedContractCostNet |
respectively. At December 31, 2023, the Company's capitalized assets related to deferred implementation costs, costs to obtain and costs to fulfill were $ 10 million, $ 362 million and $ 370 million, respectively. Costs to obtain and deferred implementation costs are primarily included in other assets and costs to fulfill are primarily included in other current assets in the Company's consolidated balance sheets. The Company recorded compensation and benefits expense of | text | 362 | monetaryItemType | text: <entity> 362 </entity> <entity type> monetaryItemType </entity type> <context> respectively. At December 31, 2023, the Company's capitalized assets related to deferred implementation costs, costs to obtain and costs to fulfill were $ 10 million, $ 362 million and $ 370 million, respectively. Costs to obtain and deferred implementation costs are primarily included in other assets and costs to fulfill are primarily included in other current assets in the Company's consolidated balance sheets. The Company recorded compensation and benefits expense of </context> | us-gaap:CapitalizedContractCostNet |
respectively. At December 31, 2023, the Company's capitalized assets related to deferred implementation costs, costs to obtain and costs to fulfill were $ 10 million, $ 362 million and $ 370 million, respectively. Costs to obtain and deferred implementation costs are primarily included in other assets and costs to fulfill are primarily included in other current assets in the Company's consolidated balance sheets. The Company recorded compensation and benefits expense of | text | 370 | monetaryItemType | text: <entity> 370 </entity> <entity type> monetaryItemType </entity type> <context> respectively. At December 31, 2023, the Company's capitalized assets related to deferred implementation costs, costs to obtain and costs to fulfill were $ 10 million, $ 362 million and $ 370 million, respectively. Costs to obtain and deferred implementation costs are primarily included in other assets and costs to fulfill are primarily included in other current assets in the Company's consolidated balance sheets. The Company recorded compensation and benefits expense of </context> | us-gaap:CapitalizedContractCostNet |
$ 1.8 billion and $ 1.6 billion for the years ended December 31, 2024, 2023 and 2022, respectively, related to the amortization of these capitalized assets. | text | 1.8 | monetaryItemType | text: <entity> 1.8 </entity> <entity type> monetaryItemType </entity type> <context> $ 1.8 billion and $ 1.6 billion for the years ended December 31, 2024, 2023 and 2022, respectively, related to the amortization of these capitalized assets. </context> | us-gaap:CapitalizedContractCostAmortization |
$ 1.8 billion and $ 1.6 billion for the years ended December 31, 2024, 2023 and 2022, respectively, related to the amortization of these capitalized assets. | text | 1.6 | monetaryItemType | text: <entity> 1.6 </entity> <entity type> monetaryItemType </entity type> <context> $ 1.8 billion and $ 1.6 billion for the years ended December 31, 2024, 2023 and 2022, respectively, related to the amortization of these capitalized assets. </context> | us-gaap:CapitalizedContractCostAmortization |
, $ 310 million and $ 372 million in 2024, 2023 and 2022, respectively. | text | 310 | monetaryItemType | text: <entity> 310 </entity> <entity type> monetaryItemType </entity type> <context> , $ 310 million and $ 372 million in 2024, 2023 and 2022, respectively. </context> | us-gaap:StockIssued1 |
, $ 310 million and $ 372 million in 2024, 2023 and 2022, respectively. | text | 372 | monetaryItemType | text: <entity> 372 </entity> <entity type> monetaryItemType </entity type> <context> , $ 310 million and $ 372 million in 2024, 2023 and 2022, respectively. </context> | us-gaap:StockIssued1 |
, $ 363 million and $ 367 million in 2024 | text | 363 | monetaryItemType | text: <entity> 363 </entity> <entity type> monetaryItemType </entity type> <context> , $ 363 million and $ 367 million in 2024 </context> | us-gaap:AllocatedShareBasedCompensationExpense |
, $ 363 million and $ 367 million in 2024 | text | 367 | monetaryItemType | text: <entity> 367 </entity> <entity type> monetaryItemType </entity type> <context> , $ 363 million and $ 367 million in 2024 </context> | us-gaap:AllocatedShareBasedCompensationExpense |
The Risk and Insurance Services segment completed 10 acquisitions in 2024: | text | 10 | integerItemType | text: <entity> 10 </entity> <entity type> integerItemType </entity type> <context> The Risk and Insurance Services segment completed 10 acquisitions in 2024: </context> | us-gaap:NumberOfBusinessesAcquired |
The Consulting segment completed 7 acquisitions in 2024: | text | 7 | integerItemType | text: <entity> 7 </entity> <entity type> integerItemType </entity type> <context> The Consulting segment completed 7 acquisitions in 2024: </context> | us-gaap:NumberOfBusinessesAcquired |
Total purchase consideration for acquisitions made in 2024 was $ 9.4 billion, which consisted of cash paid of $ 9.2 billion and deferred and estimated contingent purchase consideration of $ 190 million. Contingent purchase consideration arrangements are generally based on earnings before interest, tax, depreciation and amortization ("EBITDA") or revenue targets over a period of 2 to 4 years. The fair value of contingent purchase consideration was based on projected revenue and earnings of the acquired entities. | text | 9.4 | monetaryItemType | text: <entity> 9.4 </entity> <entity type> monetaryItemType </entity type> <context> Total purchase consideration for acquisitions made in 2024 was $ 9.4 billion, which consisted of cash paid of $ 9.2 billion and deferred and estimated contingent purchase consideration of $ 190 million. Contingent purchase consideration arrangements are generally based on earnings before interest, tax, depreciation and amortization ("EBITDA") or revenue targets over a period of 2 to 4 years. The fair value of contingent purchase consideration was based on projected revenue and earnings of the acquired entities. </context> | us-gaap:BusinessCombinationConsiderationTransferred1 |
Total purchase consideration for acquisitions made in 2024 was $ 9.4 billion, which consisted of cash paid of $ 9.2 billion and deferred and estimated contingent purchase consideration of $ 190 million. Contingent purchase consideration arrangements are generally based on earnings before interest, tax, depreciation and amortization ("EBITDA") or revenue targets over a period of 2 to 4 years. The fair value of contingent purchase consideration was based on projected revenue and earnings of the acquired entities. | text | 9.2 | monetaryItemType | text: <entity> 9.2 </entity> <entity type> monetaryItemType </entity type> <context> Total purchase consideration for acquisitions made in 2024 was $ 9.4 billion, which consisted of cash paid of $ 9.2 billion and deferred and estimated contingent purchase consideration of $ 190 million. Contingent purchase consideration arrangements are generally based on earnings before interest, tax, depreciation and amortization ("EBITDA") or revenue targets over a period of 2 to 4 years. The fair value of contingent purchase consideration was based on projected revenue and earnings of the acquired entities. </context> | us-gaap:PaymentsToAcquireBusinessesGross |
The Company incurred approximately $ 119 million and $ 45 million of acquisition and integration related expenses, in 2024 and 2023, respectively. | text | 119 | monetaryItemType | text: <entity> 119 </entity> <entity type> monetaryItemType </entity type> <context> The Company incurred approximately $ 119 million and $ 45 million of acquisition and integration related expenses, in 2024 and 2023, respectively. </context> | us-gaap:BusinessCombinationAcquisitionRelatedCosts |
The Company incurred approximately $ 119 million and $ 45 million of acquisition and integration related expenses, in 2024 and 2023, respectively. | text | 45 | monetaryItemType | text: <entity> 45 </entity> <entity type> monetaryItemType </entity type> <context> The Company incurred approximately $ 119 million and $ 45 million of acquisition and integration related expenses, in 2024 and 2023, respectively. </context> | us-gaap:BusinessCombinationAcquisitionRelatedCosts |
In 2024, these costs included approximately $ 63 million of acquisition and retention related costs in connection with the acquisition of McGriff. In 2023, the Company incurred integration costs of $ 39 million related to the acquisition of Westpac Banking Corporation's ("Westpac") financial advisory business, Advance Asset Management, and the transfer from Westpac of BT Financial Group's personal corporate pension funds to the Mercer Super Trust managed by Mercer Australia (referred to collectively, as the "Westpac Transaction"). The expenses for the Westpac Transaction related primarily to technology, consulting, legal and people related costs. | text | 63 | monetaryItemType | text: <entity> 63 </entity> <entity type> monetaryItemType </entity type> <context> In 2024, these costs included approximately $ 63 million of acquisition and retention related costs in connection with the acquisition of McGriff. In 2023, the Company incurred integration costs of $ 39 million related to the acquisition of Westpac Banking Corporation's ("Westpac") financial advisory business, Advance Asset Management, and the transfer from Westpac of BT Financial Group's personal corporate pension funds to the Mercer Super Trust managed by Mercer Australia (referred to collectively, as the "Westpac Transaction"). The expenses for the Westpac Transaction related primarily to technology, consulting, legal and people related costs. </context> | us-gaap:BusinessCombinationAcquisitionRelatedCosts |
In 2024, these costs included approximately $ 63 million of acquisition and retention related costs in connection with the acquisition of McGriff. In 2023, the Company incurred integration costs of $ 39 million related to the acquisition of Westpac Banking Corporation's ("Westpac") financial advisory business, Advance Asset Management, and the transfer from Westpac of BT Financial Group's personal corporate pension funds to the Mercer Super Trust managed by Mercer Australia (referred to collectively, as the "Westpac Transaction"). The expenses for the Westpac Transaction related primarily to technology, consulting, legal and people related costs. | text | 39 | monetaryItemType | text: <entity> 39 </entity> <entity type> monetaryItemType </entity type> <context> In 2024, these costs included approximately $ 63 million of acquisition and retention related costs in connection with the acquisition of McGriff. In 2023, the Company incurred integration costs of $ 39 million related to the acquisition of Westpac Banking Corporation's ("Westpac") financial advisory business, Advance Asset Management, and the transfer from Westpac of BT Financial Group's personal corporate pension funds to the Mercer Super Trust managed by Mercer Australia (referred to collectively, as the "Westpac Transaction"). The expenses for the Westpac Transaction related primarily to technology, consulting, legal and people related costs. </context> | us-gaap:BusinessCombinationAcquisitionRelatedCosts |
On December 31, 2024, the Company sold Oliver Wyman Group's Celent advisory business for approximately $ 24 million and recorded a gain of $ 20 million, which is included in revenue in the consolidated statements of income. | text | 24 | monetaryItemType | text: <entity> 24 </entity> <entity type> monetaryItemType </entity type> <context> On December 31, 2024, the Company sold Oliver Wyman Group's Celent advisory business for approximately $ 24 million and recorded a gain of $ 20 million, which is included in revenue in the consolidated statements of income. </context> | us-gaap:ProceedsFromDivestitureOfBusinesses |
On December 31, 2024, the Company sold Oliver Wyman Group's Celent advisory business for approximately $ 24 million and recorded a gain of $ 20 million, which is included in revenue in the consolidated statements of income. | text | 20 | monetaryItemType | text: <entity> 20 </entity> <entity type> monetaryItemType </entity type> <context> On December 31, 2024, the Company sold Oliver Wyman Group's Celent advisory business for approximately $ 24 million and recorded a gain of $ 20 million, which is included in revenue in the consolidated statements of income. </context> | us-gaap:GainLossOnSaleOfBusiness |
On January 1, 2024, the Company sold its Mercer U.K. pension administration and U.S. health and benefits administration businesses for approximately $ 120 million and recorded a net gain of $ 35 million, included in revenue in the consolidated statement of income. As part of the disposition of the businesses, the Company | text | 120 | monetaryItemType | text: <entity> 120 </entity> <entity type> monetaryItemType </entity type> <context> On January 1, 2024, the Company sold its Mercer U.K. pension administration and U.S. health and benefits administration businesses for approximately $ 120 million and recorded a net gain of $ 35 million, included in revenue in the consolidated statement of income. As part of the disposition of the businesses, the Company </context> | us-gaap:ProceedsFromDivestitureOfBusinesses |
On January 1, 2024, the Company sold its Mercer U.K. pension administration and U.S. health and benefits administration businesses for approximately $ 120 million and recorded a net gain of $ 35 million, included in revenue in the consolidated statement of income. As part of the disposition of the businesses, the Company | text | 35 | monetaryItemType | text: <entity> 35 </entity> <entity type> monetaryItemType </entity type> <context> On January 1, 2024, the Company sold its Mercer U.K. pension administration and U.S. health and benefits administration businesses for approximately $ 120 million and recorded a net gain of $ 35 million, included in revenue in the consolidated statement of income. As part of the disposition of the businesses, the Company </context> | us-gaap:GainLossOnSaleOfBusiness |
incurred exit costs of $ 18 million in the first quarter of 2024. These costs are included in expenses in the consolidated statements of income. | text | 18 | monetaryItemType | text: <entity> 18 </entity> <entity type> monetaryItemType </entity type> <context> incurred exit costs of $ 18 million in the first quarter of 2024. These costs are included in expenses in the consolidated statements of income. </context> | us-gaap:BusinessExitCosts1 |
The Risk and Insurance Services segment completed 9 acquisitions in 2023: | text | 9 | integerItemType | text: <entity> 9 </entity> <entity type> integerItemType </entity type> <context> The Risk and Insurance Services segment completed 9 acquisitions in 2023: </context> | us-gaap:NumberOfBusinessesAcquired |
The Consulting segment completed 5 acquisitions in 2023: | text | 5 | integerItemType | text: <entity> 5 </entity> <entity type> integerItemType </entity type> <context> The Consulting segment completed 5 acquisitions in 2023: </context> | us-gaap:NumberOfBusinessesAcquired |
Total purchase consideration for acquisitions made in 2023 was $ 1.2 billion, which consisted of cash paid of $ 1.1 billion and deferred and estimated contingent purchase consideration of $ 41 million. Contingent purchase consideration arrangements are generally based primarily on EBITDA or revenue targets over a period of 2 to 4 years. The fair value of the contingent purchase consideration was based on projected revenue and earnings of the acquired entities. In 2023, the Company also paid $ 67 million of deferred purchase consideration and $ 176 million of contingent purchase consideration related to acquisitions made in prior years. Estimated fair values of assets acquired and liabilities assumed are subject to adjustment when purchase accounting is finalized. | text | 1.2 | monetaryItemType | text: <entity> 1.2 </entity> <entity type> monetaryItemType </entity type> <context> Total purchase consideration for acquisitions made in 2023 was $ 1.2 billion, which consisted of cash paid of $ 1.1 billion and deferred and estimated contingent purchase consideration of $ 41 million. Contingent purchase consideration arrangements are generally based primarily on EBITDA or revenue targets over a period of 2 to 4 years. The fair value of the contingent purchase consideration was based on projected revenue and earnings of the acquired entities. In 2023, the Company also paid $ 67 million of deferred purchase consideration and $ 176 million of contingent purchase consideration related to acquisitions made in prior years. Estimated fair values of assets acquired and liabilities assumed are subject to adjustment when purchase accounting is finalized. </context> | us-gaap:BusinessCombinationConsiderationTransferred1 |
Total purchase consideration for acquisitions made in 2023 was $ 1.2 billion, which consisted of cash paid of $ 1.1 billion and deferred and estimated contingent purchase consideration of $ 41 million. Contingent purchase consideration arrangements are generally based primarily on EBITDA or revenue targets over a period of 2 to 4 years. The fair value of the contingent purchase consideration was based on projected revenue and earnings of the acquired entities. In 2023, the Company also paid $ 67 million of deferred purchase consideration and $ 176 million of contingent purchase consideration related to acquisitions made in prior years. Estimated fair values of assets acquired and liabilities assumed are subject to adjustment when purchase accounting is finalized. | text | 1.1 | monetaryItemType | text: <entity> 1.1 </entity> <entity type> monetaryItemType </entity type> <context> Total purchase consideration for acquisitions made in 2023 was $ 1.2 billion, which consisted of cash paid of $ 1.1 billion and deferred and estimated contingent purchase consideration of $ 41 million. Contingent purchase consideration arrangements are generally based primarily on EBITDA or revenue targets over a period of 2 to 4 years. The fair value of the contingent purchase consideration was based on projected revenue and earnings of the acquired entities. In 2023, the Company also paid $ 67 million of deferred purchase consideration and $ 176 million of contingent purchase consideration related to acquisitions made in prior years. Estimated fair values of assets acquired and liabilities assumed are subject to adjustment when purchase accounting is finalized. </context> | us-gaap:PaymentsToAcquireBusinessesGross |
In January 2023, the Company entered into an agreement for the sale of an individual financial advisory business in Canada which was completed in May 2023. As a result, the Company recorded a loss of $ 17 million in 2023, primarily related to the write-down of the customer relationship intangible assets. The loss is included in revenue in the consolidated statements of income. | text | 17 | monetaryItemType | text: <entity> 17 </entity> <entity type> monetaryItemType </entity type> <context> In January 2023, the Company entered into an agreement for the sale of an individual financial advisory business in Canada which was completed in May 2023. As a result, the Company recorded a loss of $ 17 million in 2023, primarily related to the write-down of the customer relationship intangible assets. The loss is included in revenue in the consolidated statements of income. </context> | us-gaap:GainLossOnSaleOfBusiness |
In connection with the disposition of the Mercer U.S. affinity business in 2022, the Company transferred to the buyer an additional $ 24 million of cash and cash equivalents held in a fiduciary capacity in the first quarter of 2023. | text | 24 | monetaryItemType | text: <entity> 24 </entity> <entity type> monetaryItemType </entity type> <context> In connection with the disposition of the Mercer U.S. affinity business in 2022, the Company transferred to the buyer an additional $ 24 million of cash and cash equivalents held in a fiduciary capacity in the first quarter of 2023. </context> | us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested |
In the second quarter of 2023, the Company purchased the remaining interest in a subsidiary for $ 139 million. | text | 139 | monetaryItemType | text: <entity> 139 </entity> <entity type> monetaryItemType </entity type> <context> In the second quarter of 2023, the Company purchased the remaining interest in a subsidiary for $ 139 million. </context> | us-gaap:PaymentsToMinorityShareholders |
Includes $ 5.2 billion from the acquisition of McGriff in 2024. | text | 5.2 | monetaryItemType | text: <entity> 5.2 </entity> <entity type> monetaryItemType </entity type> <context> Includes $ 5.2 billion from the acquisition of McGriff in 2024. </context> | us-gaap:GoodwillAcquiredDuringPeriod |
The goodwill acquired in 2024 included approximately $ 1.8 billion and $ 88 million in the Risk and Insurance Services and Consulting segments, respectively, which is deductible for tax purposes. The goodwill acquired in | text | 1.8 | monetaryItemType | text: <entity> 1.8 </entity> <entity type> monetaryItemType </entity type> <context> The goodwill acquired in 2024 included approximately $ 1.8 billion and $ 88 million in the Risk and Insurance Services and Consulting segments, respectively, which is deductible for tax purposes. The goodwill acquired in </context> | us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount |
The goodwill acquired in 2024 included approximately $ 1.8 billion and $ 88 million in the Risk and Insurance Services and Consulting segments, respectively, which is deductible for tax purposes. The goodwill acquired in | text | 88 | monetaryItemType | text: <entity> 88 </entity> <entity type> monetaryItemType </entity type> <context> The goodwill acquired in 2024 included approximately $ 1.8 billion and $ 88 million in the Risk and Insurance Services and Consulting segments, respectively, which is deductible for tax purposes. The goodwill acquired in </context> | us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount |
included approximately $ 230 million and $ 12 million in the Risk and Insurance Service and Consulting segments, respectively, which is deductible for tax purposes. | text | 230 | monetaryItemType | text: <entity> 230 </entity> <entity type> monetaryItemType </entity type> <context> included approximately $ 230 million and $ 12 million in the Risk and Insurance Service and Consulting segments, respectively, which is deductible for tax purposes. </context> | us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount |
included approximately $ 230 million and $ 12 million in the Risk and Insurance Service and Consulting segments, respectively, which is deductible for tax purposes. | text | 12 | monetaryItemType | text: <entity> 12 </entity> <entity type> monetaryItemType </entity type> <context> included approximately $ 230 million and $ 12 million in the Risk and Insurance Service and Consulting segments, respectively, which is deductible for tax purposes. </context> | us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount |
, is $ 18.8 billion for Risk and Insurance Services and $ 4.5 billion for Consulting. | text | 18.8 | monetaryItemType | text: <entity> 18.8 </entity> <entity type> monetaryItemType </entity type> <context> , is $ 18.8 billion for Risk and Insurance Services and $ 4.5 billion for Consulting. </context> | us-gaap:Goodwill |
, is $ 18.8 billion for Risk and Insurance Services and $ 4.5 billion for Consulting. | text | 4.5 | monetaryItemType | text: <entity> 4.5 </entity> <entity type> monetaryItemType </entity type> <context> , is $ 18.8 billion for Risk and Insurance Services and $ 4.5 billion for Consulting. </context> | us-gaap:Goodwill |
Customer relationships and Other include $ 2.1 billion and | text | 2.1 | monetaryItemType | text: <entity> 2.1 </entity> <entity type> monetaryItemType </entity type> <context> Customer relationships and Other include $ 2.1 billion and </context> | us-gaap:FiniteLivedIntangibleAssetsGross |
e was $ 377 million, $ 343 million, and $ 338 million for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 377 | monetaryItemType | text: <entity> 377 </entity> <entity type> monetaryItemType </entity type> <context> e was $ 377 million, $ 343 million, and $ 338 million for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:AmortizationOfIntangibleAssets |
e was $ 377 million, $ 343 million, and $ 338 million for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 343 | monetaryItemType | text: <entity> 343 </entity> <entity type> monetaryItemType </entity type> <context> e was $ 377 million, $ 343 million, and $ 338 million for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:AmortizationOfIntangibleAssets |
e was $ 377 million, $ 343 million, and $ 338 million for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 338 | monetaryItemType | text: <entity> 338 </entity> <entity type> monetaryItemType </entity type> <context> e was $ 377 million, $ 343 million, and $ 338 million for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:AmortizationOfIntangibleAssets |
Net of valuation allowances of $ 75 million in 2024 and $ 53 million in 2023. | text | 75 | monetaryItemType | text: <entity> 75 </entity> <entity type> monetaryItemType </entity type> <context> Net of valuation allowances of $ 75 million in 2024 and $ 53 million in 2023. </context> | us-gaap:DeferredTaxAssetsValuationAllowance |
Net of valuation allowances of $ 75 million in 2024 and $ 53 million in 2023. | text | 53 | monetaryItemType | text: <entity> 53 </entity> <entity type> monetaryItemType </entity type> <context> Net of valuation allowances of $ 75 million in 2024 and $ 53 million in 2023. </context> | us-gaap:DeferredTaxAssetsValuationAllowance |
The amount of cumulative undistributed earnings that are indefinitely reinvested in non-U.S. subsidiaries is approximately $ 860 million at December 31, 2024. While no additional U.S. federal income tax would be required if such earnings were repatriated, additional state and withholding taxes would apply. The amount of these additional taxes is estimated to be approximately $ 80 million. | text | 860 | monetaryItemType | text: <entity> 860 </entity> <entity type> monetaryItemType </entity type> <context> The amount of cumulative undistributed earnings that are indefinitely reinvested in non-U.S. subsidiaries is approximately $ 860 million at December 31, 2024. While no additional U.S. federal income tax would be required if such earnings were repatriated, additional state and withholding taxes would apply. The amount of these additional taxes is estimated to be approximately $ 80 million. </context> | us-gaap:UndistributedEarningsOfForeignSubsidiaries |
The amount of cumulative undistributed earnings that are indefinitely reinvested in non-U.S. subsidiaries is approximately $ 860 million at December 31, 2024. While no additional U.S. federal income tax would be required if such earnings were repatriated, additional state and withholding taxes would apply. The amount of these additional taxes is estimated to be approximately $ 80 million. | text | 80 | monetaryItemType | text: <entity> 80 </entity> <entity type> monetaryItemType </entity type> <context> The amount of cumulative undistributed earnings that are indefinitely reinvested in non-U.S. subsidiaries is approximately $ 860 million at December 31, 2024. While no additional U.S. federal income tax would be required if such earnings were repatriated, additional state and withholding taxes would apply. The amount of these additional taxes is estimated to be approximately $ 80 million. </context> | us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings |
A valuation allowance was recorded to adjust deferred tax assets to the amount that the Company believes is more likely than not to be realized. Valuation allowances had a net increase of $ 24 million in 2024, and a net decrease of $ 110 million, and $ 1 million in 2023, and 2022, respectively. Adjustments of the beginning of the year balances of valuation allowances had no impact to the income tax expense in 2024. Adjustments of the beginning of the year balances of valuation allowances decreased income tax expense by $ 94 million in 2023 and $ 5 million in 2022. Approximately 10 % of the Company’s net operating loss carryforwards expire from 2025 through 2038, and the remaining 90 % are unlimited. The gross deferred tax assets of the potential tax benefit from net operating loss carryforwards at the end of 2024 is primarily comprised of non-U.S. tax benefits of $ 380 million. | text | 24 | monetaryItemType | text: <entity> 24 </entity> <entity type> monetaryItemType </entity type> <context> A valuation allowance was recorded to adjust deferred tax assets to the amount that the Company believes is more likely than not to be realized. Valuation allowances had a net increase of $ 24 million in 2024, and a net decrease of $ 110 million, and $ 1 million in 2023, and 2022, respectively. Adjustments of the beginning of the year balances of valuation allowances had no impact to the income tax expense in 2024. Adjustments of the beginning of the year balances of valuation allowances decreased income tax expense by $ 94 million in 2023 and $ 5 million in 2022. Approximately 10 % of the Company’s net operating loss carryforwards expire from 2025 through 2038, and the remaining 90 % are unlimited. The gross deferred tax assets of the potential tax benefit from net operating loss carryforwards at the end of 2024 is primarily comprised of non-U.S. tax benefits of $ 380 million. </context> | us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount |
A valuation allowance was recorded to adjust deferred tax assets to the amount that the Company believes is more likely than not to be realized. Valuation allowances had a net increase of $ 24 million in 2024, and a net decrease of $ 110 million, and $ 1 million in 2023, and 2022, respectively. Adjustments of the beginning of the year balances of valuation allowances had no impact to the income tax expense in 2024. Adjustments of the beginning of the year balances of valuation allowances decreased income tax expense by $ 94 million in 2023 and $ 5 million in 2022. Approximately 10 % of the Company’s net operating loss carryforwards expire from 2025 through 2038, and the remaining 90 % are unlimited. The gross deferred tax assets of the potential tax benefit from net operating loss carryforwards at the end of 2024 is primarily comprised of non-U.S. tax benefits of $ 380 million. | text | 110 | monetaryItemType | text: <entity> 110 </entity> <entity type> monetaryItemType </entity type> <context> A valuation allowance was recorded to adjust deferred tax assets to the amount that the Company believes is more likely than not to be realized. Valuation allowances had a net increase of $ 24 million in 2024, and a net decrease of $ 110 million, and $ 1 million in 2023, and 2022, respectively. Adjustments of the beginning of the year balances of valuation allowances had no impact to the income tax expense in 2024. Adjustments of the beginning of the year balances of valuation allowances decreased income tax expense by $ 94 million in 2023 and $ 5 million in 2022. Approximately 10 % of the Company’s net operating loss carryforwards expire from 2025 through 2038, and the remaining 90 % are unlimited. The gross deferred tax assets of the potential tax benefit from net operating loss carryforwards at the end of 2024 is primarily comprised of non-U.S. tax benefits of $ 380 million. </context> | us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount |
A valuation allowance was recorded to adjust deferred tax assets to the amount that the Company believes is more likely than not to be realized. Valuation allowances had a net increase of $ 24 million in 2024, and a net decrease of $ 110 million, and $ 1 million in 2023, and 2022, respectively. Adjustments of the beginning of the year balances of valuation allowances had no impact to the income tax expense in 2024. Adjustments of the beginning of the year balances of valuation allowances decreased income tax expense by $ 94 million in 2023 and $ 5 million in 2022. Approximately 10 % of the Company’s net operating loss carryforwards expire from 2025 through 2038, and the remaining 90 % are unlimited. The gross deferred tax assets of the potential tax benefit from net operating loss carryforwards at the end of 2024 is primarily comprised of non-U.S. tax benefits of $ 380 million. | text | 1 | monetaryItemType | text: <entity> 1 </entity> <entity type> monetaryItemType </entity type> <context> A valuation allowance was recorded to adjust deferred tax assets to the amount that the Company believes is more likely than not to be realized. Valuation allowances had a net increase of $ 24 million in 2024, and a net decrease of $ 110 million, and $ 1 million in 2023, and 2022, respectively. Adjustments of the beginning of the year balances of valuation allowances had no impact to the income tax expense in 2024. Adjustments of the beginning of the year balances of valuation allowances decreased income tax expense by $ 94 million in 2023 and $ 5 million in 2022. Approximately 10 % of the Company’s net operating loss carryforwards expire from 2025 through 2038, and the remaining 90 % are unlimited. The gross deferred tax assets of the potential tax benefit from net operating loss carryforwards at the end of 2024 is primarily comprised of non-U.S. tax benefits of $ 380 million. </context> | us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.